Company: SXTPW
Filing Date: 2025-06-06
Form Type: DRS
Source: 0001213900-25-052232
Chunk: 42

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-06-06
Form: DRS
Chunk 42
---
 no guarantee that the Warrant Stockholder Approval will ever be obtained. If we are unable to obtain the
Warrant Stockholder Approval, the Warrants may have no value.

Regardless of the amount of cash that is raised in this public offering, we will require additional financing in the future to continue as a going concern.

We will not generate sufficient revenues in the
foreseeable future to fund our operations. Accordingly, regardless of the amount of net proceeds that are raised in this offering, we
will require additional financing in the future to continue as a going concern. If we are unable to raise additional capital or generate
sufficient cash from operations to adequately fund our operations, we will, at a minimum, need to curtail planned business activities
to reduce costs, which we expect will harm our ability to execute on our business plan and continue operations.

We have broad discretion in the use of the net proceeds from this offering and may not use them effectively.

Our management will have broad discretion in the
application of the net proceeds from this offering, including for any of the purposes described in the section titled “Use of Proceeds,” and you will not have the opportunity as part of your investment decision to assess whether the net proceeds will
be used appropriately. Because of the number and variability of factors that will determine our use of the net proceeds from this offering,
their ultimate use may vary substantially from their currently intended use. Our management might not apply our net proceeds in ways that
ultimately increase the value of your investment. We currently intend to use the net proceeds to us from this offering for working
capital and general corporate purposes.

Our expected use of net proceeds from this offering
represents our current intentions based upon our present plans and business condition. As of the date of this prospectus, we cannot predict
with certainty all of the particular uses for the net proceeds to be received upon the completion of this offering, or the amounts that
we will actually spend on the uses set forth above. The amounts and timing of our actual use of the net proceeds will vary depending on
numerous factors. As a result, our management will have broad discretion in the application of the net proceeds, and investors will be
relying on our judgment regarding the application of the net proceeds of this offering.

The failure by our management to apply these funds
effectively could harm our business. Pending their use, we may invest the net proceeds from this offering in short-term, investment-grade,
interest-bearing securities. These investments may not yield a favorable